Blood Purification Equipment Market size will substantially grow between 2023 and 2032 due to the increasing cases of kidney failures and the prevalence of autoimmune diseases.
According to the American College of Rheumatology, rheumatoid arthritis (RA) is the most common type of autoimmune arthritis. The increasing burden of autoimmune disorders including psoriatic arthritis, celiac disease, Systemic lupus erythematosus (SLE), Grave’s disease, and Hashimoto’s thyroiditis will accelerate the need for adequate therapeutics and blood purification equipment.
In response, healthcare facilities, hospitals, and clinics are increasingly installing advanced blood purification equipment in order to provide seamless services. Moreover, the growing popularity of portable and automated medical devices for continuous blood purification, hemoperfusion, and hemodialysis will complement the blood purification equipment market outlook.
In terms of application, the blood purification equipment industry share from continuous blood purification equipment is slated to rise significantly by 2032. This type of equipment is widely used in continuous renal replacement therapy (CRRT). With the growing incidences of acute kidney injury (AKI), the need for CRRT is expected to increase remarkably, driving the demand for blood purification equipment. Additionally, the growing burden of cancer is expected to promote the installation of CRRT therapy equipment to combat the high risk of AKI.
With respect to end-users, hospitals will account for a notable share of the blood purification equipment market over 2032 due to the rising prevalence of chronic diseases such as diabetes. The emergence of novel diseases has pushed several governments to scale up investments in hospital facilities to strengthen healthcare infrastructures, thus driving the industry trends.
North America blood purification equipment industry size is poised to expand at a substantial rate by 2032 led by the surging growth for hemodialysis in the U.S. The presence of a large patient population requiring chronic dialysis is expected to spur the adoption of blood purification equipment across hospitals and other healthcare facilities.
The competitive landscape of the global blood purification equipment market includes NxStage Medical Inc., Toray Medical Co Ltd., Accel Diagnostics LLC., Stellarray, Inc., CytoSorbents Corp, Circle Biologics, LLC, Aethlon Medical Inc, Cerus Corp Company, Jafron, Medtronic, and Spectral Medical Inc. These companies are developing innovative products to expand the product application scope while enhancing their customer base.